Morita Y, Nomura A, Yuzawa Y, Nishikawa K, Hotta N, Shimizu F, Matsuo S
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.
J Am Soc Nephrol. 1997 Sep;8(9):1363-72. doi: 10.1681/ASN.V891363.
Persistent proteinuria and tubulointerstitial lesions are important signs of progressive renal disease. The purpose of this study was to assess the role of complement in the development of tubulointerstitial lesions in rats with proteinuria due to primary glomerulonephritis. Mesangial proliferative glomerulonephritis was induced in mononephrectomized rats by intravenous injection of monoclonal antibody (mAb) 1-22-3 (Clin Exp Immunol 102: 181-185, 1995). As early as 24 h after the injection, proteinuria became evident, persisted throughout the observation period, and was associated with mesangial cell proliferation and tubulointerstitial lesions when examined at 7 and 14 d after mAb administration. Deposition of rat C3 and C5b-9 was observed at the luminal surface of proximal tubules and in cellular debris present in the tubular lumen (group I). Rats injected with mAb 1-22-3 and depleted of complement by injections of cobra venom factor starting at day 3 developed glomerulonephritis and proteinuria comparable to rats of group I, but complement deposition in the tubules and the tubulointerstitial lesions were markedly reduced (group II). Rats in group III were injected with mAb and, from day 3, with soluble complement receptor type 1, which became detectable at the luminal surface of proximal tubules and in the urine. Deposition of C5b-9 in tubular cells was not detectable, and the severity of tubulointerstitial lesions was reduced compared with rats in group I. These results indicate that, in this model of primary mesangial proliferative glomerulonephritis with proteinuria, the development of tubulointerstitial lesions is associated with activation of serum complement at the level of tubular brush border, and tubulointerstitial lesions can be reduced by inhibition of complement activity.
持续性蛋白尿和肾小管间质损伤是进行性肾脏疾病的重要标志。本研究的目的是评估补体在原发性肾小球肾炎所致蛋白尿大鼠肾小管间质损伤发展过程中的作用。通过静脉注射单克隆抗体(mAb)1-22-3(《临床与实验免疫学》102: 181-185, 1995),在单侧肾切除的大鼠中诱导系膜增生性肾小球肾炎。早在注射后24小时,蛋白尿就变得明显,并在整个观察期持续存在,在给予单克隆抗体后7天和14天检查时,蛋白尿与系膜细胞增殖和肾小管间质损伤相关。在近端小管的管腔表面和肾小管腔中的细胞碎片中观察到大鼠C3和C5b-9的沉积(第一组)。从第3天开始注射眼镜蛇毒因子以消耗补体的注射mAb 1-22-3的大鼠发生了与第一组大鼠相当的肾小球肾炎和蛋白尿,但肾小管中的补体沉积和肾小管间质损伤明显减少(第二组)。第三组大鼠注射了单克隆抗体,并从第3天开始注射可溶性1型补体受体,其在近端小管的管腔表面和尿液中可检测到。未检测到肾小管细胞中C5b-9的沉积,与第一组大鼠相比,肾小管间质损伤的严重程度降低。这些结果表明,在这种伴有蛋白尿的原发性系膜增生性肾小球肾炎模型中,肾小管间质损伤的发展与肾小管刷状缘水平的血清补体激活有关,并且通过抑制补体活性可以减轻肾小管间质损伤。